Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HA-1004 inhibits cGKI, MYLK, PKA, PKC, and calcium channel protein.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 100,500 | |||
10 mg | 在庫あり | ¥ 148,500 | |||
25 mg | 在庫あり | ¥ 226,500 | |||
50 mg | 在庫あり | ¥ 317,000 | |||
100 mg | 在庫あり | ¥ 427,000 | |||
500 mg | 在庫あり | ¥ 854,000 |
説明 | HA-1004 inhibits cGKI, MYLK, PKA, PKC, and calcium channel protein. |
In vitro | HA-100 inhibits MLC-kinase and PKC competitively with respect to ATP, with Kis of 61 and 6.5 μM, respectively [2]. |
分子量 | 293.34 |
分子式 | C12H15N5O2S |
CAS No. | 91742-10-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11 mg/mL (37.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HA-1004 91742-10-8 Cell Cycle/Checkpoint Chromatin/Epigenetic Cytoskeletal Signaling Metabolism Tyrosine Kinase/Adaptors Serine/threonin kinase PKC PKA HA 1004 HA1004 Inhibitor inhibitor inhibit